Stand Up To Cancer® (SU2C) today announced grants to several teams of leading cancer investigators in support of cutting-edge research in a variety of cancers including head and neck, pediatric, pancreatic, breast, rectal and gastro-esophageal cancers, as well as research focused on how the microbiome communicates with the immune system.
These new grants emphasize SU2C's support of collaborative, trailblazing research that pushes the field forward and helps people impacted by some of the most common or difficult-to-treat cancers. With an emphasis on answering critical questions about how to tailor and personalize targeted cancer treatments, these projects have the potential to increase survival with less side effects."
Julian Adams, Ph.D., President and CEO of SU2C
Below are the recently funded SU2C grants.
Three 2024 SU2C Innovation in Collaboration Awards were granted during the annual SU2C Scientific Summit earlier this year. These awards include two collaborators from the SU2C scientific community, including scientific leaders, senior researchers, and early career investigators. The hallmark of these awards is their ability to quickly spark the "aha" moments; ideas are submitted, reviewed and awarded at the summit.